LL-37 – 5MG
This product, LL-37, a synthetic compound based on the human cathelicidin antimicrobial compound (CAMP) sequence, is offered in a 5mg quantity for research use only.
Research Context
The LL-37 compound has garnered significant interest due to its multifaceted biological activities, including its role as an antimicrobial agent and its potential involvement in various physiological processes such as inflammation, wound healing, and immune modulation. The CAMP family of compound , of which LL-37 is a member, plays critical roles in innate immunity.
Research Overview
The compound sequence of LL-37 is derived from the N-terminal region of human cathelicidin protein. It has been extensively studied for its antimicrobial properties against various pathogens, including bacteria and fungi. Moreover, LL-37’s ability to interact with cell membranes and influence cellular signaling pathways makes it a valuable tool in exploring host-pathogen interactions.
Key Research Focus Areas
- Antimicrobial Activity: Investigation of the mechanisms by which LL-37 exerts its antimicrobial effects, including membrane disruption and modulation of intracellular signaling pathways.
- Inflammation Modulation: Analysis of how LL-37 influences inflammatory responses, particularly in the context of immune cell activation and cytokine release.
- Wound Healing: Examination of the role of LL-37 in wound repair processes, including its effects on cell migration, proliferation, and angiogenesis.
- Immune Response Regulation: Study of how LL-37 modulates immune responses, potentially offering insights into therapeutic applications for immunological disorders.
Compliance Disclaimer
This product is intended for research use only. Not for human or animal consumption. Any use in clinical settings must be evaluated and approved by appropriate regulatory authorities. This material should not be used for any purpose other than as specified herein.
| Size | 5MG |
|---|
